COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    cannabidiol | depression
Previous Study | Return to List | Next Study

Cannabidiol as an Adjunctive Treatment for Bipolar Depression (CBDBD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03310593
Recruitment Status : Recruiting
First Posted : October 16, 2017
Last Update Posted : March 5, 2020
Federal University of Rio Grande do Sul
University of Sao Paulo
Information provided by (Responsible Party):
Hospital de Clinicas de Porto Alegre

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : April 2022